Diabetes mellitus (DM) is a chronic metabolic disease which is independently associated
with unfavorable clinical outcomes in patients with atrial fibrillation (AF). Few real-world data …

Background The prevalence of both atrial fibrillation (AF) and diabetes mellitus (DM) are
rising, and these conditions often occur together. Also, DM is an independent risk factor for …

Objective To address gaps in the data comparing non–vitamin K antagonist oral
anticoagulants (NOACs) and warfarin among patients with nonvalvular atrial fibrillation …

In patients with atrial fibrillation (AF), the safety and efficacy of nonvitamin K antagonist oral
anticoagulants (NOACs) vs warfarin according to diabetes mellitus (DM) status are not …

Background Recent data have suggested that insulin-requiring diabetes mostly contributes
to the overall increase of thromboembolic risk in patients with atrial fibrillation (AF) on …

Background Diabetes mellitus is an independent risk factor for stroke and atrial fibrillation.
Therefore, the risk/benefit profile of the oral factor Xa inhibitor edoxaban stratified by …

Background. This meta‐analysis was performed to compare the efficacy and safety of direct
oral anticoagulants (DOACs) with vitamin K antagonists (VKAs) for stroke prevention in real …

Type 2 diabetes (T2D) is an independent risk factor of stroke and systemic embolism in
patients with atrial fibrillation (AF), and T2D patients with AF‐associated stroke seem to have …

Aims Concomitant atrial fibrillation (AF) and diabetes mellitus (DM) increases the risk of
stroke and systemic embolic events (SEE). This meta-analysis assessed the benefit/risk …

Objective This study incorporates the results of subgroup analyses of currently published
randomized controlled trials (RCTs) and real-world cohort studies to compare the …